November 19th 2024
Reactogenicity of mRNA COVID-19 with inactivated influenza vaccine was similar whether given at same time or separated by 1-2 weeks.
Flu Vaccination Rates Rise for Pregnant Women but Still Fall Short
December 13th 2016While flu vaccination rates for pregnant women have more than doubled since 2005, a new report from the Centers for Disease Control and Prevention says that at least half of expectant mothers are missing out on the protective benefits of the flu shot.
Read More
New Research Could Offer Novel Treatments for Astrovirus Infections
December 5th 2016New research from University of California Santa Cruz biologists shows how antibodies work to stop astrovirus infections, offering a potentially new way to develop a vaccine and treatment for this infection.
Read More
What Do Stakeholders Think About the GAP for Influenza Vaccines' First 10 Years?
December 5th 2016Ten years ago in Geneva, the World Health Organization (WHO) unveiled what is now called the Global Action Plan for Influenza Vaccines (GAP), a comprehensive approach to meeting the demand for vaccines should there be a pandemic anywhere in the world. How is it doing?
Read More
NIH Launches First New HIV Vaccine Efficacy Study in 7 Years in South Africa
November 29th 2016The first HIV vaccine efficacy study in seven years is currently being conducted in South Africa, with researchers testing if a new vaccine regimen called HVTN 702 can provide adequate protection against HIV.
Read More
Measles Control & Eradication Efforts Fall Short of 2015 WHA Goals
November 15th 2016A recent analysis by the Centers for Disease Control and Prevention found that strides have been made in the fight against measles; however, the work still falls short of goals set by the World Health Assembly (WHA).
Read More
A Preponderance of Missed Opportunities to Administer the Human Papillomavirus Vaccine
November 10th 2016Despite the Centers for Disease Control and Prevention's recommendation that the human papillomavirus (HPV) vaccine be routinely given to adolescents and young adults, administration rates for the vaccine are still low.
Read More